Medpace Holdings Stock Today
| MEDP Stock | USD 387.14 7.86 1.99% |
Performance18 of 100
| Odds Of DistressLess than 2
|
Medpace Holdings is selling at 387.14 as of the 15th of April 2024; that is -1.99 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 387.13. Medpace Holdings has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Medpace Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of March 2024 and ending today, the 15th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of August 2016 | Category Healthcare | Classification Health Care |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 30.98 M outstanding shares of which 946.6 K shares are now shorted by private and institutional investors with about 3.62 trading days to cover. More on Medpace Holdings
Moving together with Medpace Stock
| 0.77 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.65 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.76 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
| 0.61 | ERNA | Eterna Therapeutics | PairCorr |
Moving against Medpace Stock
| 0.79 | BNR | Burning Rock BiotechLtd Financial Report 4th of June 2024 | PairCorr |
| 0.69 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.65 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Medpace Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medpace Holdings' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medpace Holdings or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | August Troendle | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Health Care, NASDAQ Composite, SP Midcap 400, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Medpace Holdings report their recommendations after researching Medpace Holdings' financial statements, talking to executives and customers, or listening in on Medpace Holdings' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Medpace Holdings. The Medpace consensus assessment is calculated by taking the average forecast from all of the analysts covering Medpace Holdings. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Medpace Holdings' liquidity, profitability, solvency, and operating efficiency, Medpace Holdings is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of Medpace Holdings is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medpace Holdings' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Medpace Holdings' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Medpace Holdings' financial leverage. It provides some insight into what part of Medpace Holdings' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medpace Holdings (MEDP) is traded on NASDAQ Exchange in USA. It is located in 5375 Medpace Way, Cincinnati, OH, United States, 45227 and employs 5,900 people. Medpace Holdings is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medpace Holdings's market, we take the total number of its shares issued and multiply it by Medpace Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medpace Holdings conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 30.98 M outstanding shares of which 946.6 K shares are now shorted by private and institutional investors with about 3.62 trading days to cover.
Medpace Holdings currently holds about 31.01 M in cash with 433.37 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0.
Check Medpace Holdings Probability Of Bankruptcy
Ownership AllocationMedpace Holdings maintains a total of 30.98 Million outstanding shares. The majority of Medpace Holdings outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medpace Holdings to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medpace Holdings. Please pay attention to any change in the institutional holdings of Medpace Holdings as this could imply that something significant has changed or is about to change at the company. Also note that almost three hundred nine thousand eight hundred thirty-two invesors are currently shorting Medpace Holdings expressing very little confidence in its future performance.
Check Medpace Ownership Details
Medpace Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Medpace Holdings jumping above the current price in 90 days from now is about 31.13%. The Medpace Holdings probability density function shows the probability of Medpace Holdings stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Medpace Holdings has a beta of 0.8784. This indicates Medpace Holdings market returns are sensible to returns on the market. As the market goes up or down, Medpace Holdings is expected to follow. Additionally, medpace Holdings has an alpha of 0.3719, implying that it can generate a 0.37 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Medpace Holdings to move above the current price in 90 days from now is about 31.13 (This Medpace Holdings probability density function shows the probability of Medpace Stock to fall within a particular range of prices over 90 days) .
Medpace Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Medpace Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medpace Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medpace Holdings' value.| Instituion | Recorded On | Shares | |
| American Capital Management Inc | 2023-09-30 | 420.9 K | |
| Wellington Management Company Llp | 2023-12-31 | 414.6 K | |
| Bessemer Group Inc | 2023-12-31 | 388.7 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 373.2 K | |
| Td Global Investment Solutions – Td Epoch | 2023-12-31 | 352.5 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 346 K | |
| Los Angeles Capital Management Llc | 2023-12-31 | 254.1 K | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 252.9 K | |
| Renaissance Technologies Corp | 2023-12-31 | 251.4 K | |
| Vanguard Group Inc | 2023-12-31 | 2.6 M | |
| Blackrock Inc | 2023-12-31 | 2.4 M |
Medpace Holdings Historical Income Statement
Medpace Holdings Income Statement is one of the three primary financial statements used for reporting Medpace's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Medpace Holdings revenue and expense. Medpace Holdings Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Medpace Holdings' Income Tax Expense is relatively stable compared to the past year. As of 04/15/2024, Net Income From Continuing Ops is likely to grow to about 286.8 M, while Other Operating Expenses is likely to drop slightly above 775.9 M. View More FundamentalsMedpace Stock Against Markets
Picking the right benchmark for Medpace Holdings stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Medpace Holdings stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Medpace Holdings is critical whether you are bullish or bearish towards Medpace Holdings at a given time. Please also check how Medpace Holdings' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medpace Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Medpace Holdings Corporate Directors
Medpace Holdings corporate directors refer to members of a Medpace Holdings board of directors. The board of directors generally takes responsibility for the Medpace Holdings' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Medpace Holdings' board members must vote for the resolution. The Medpace Holdings board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Cornelius McCarthy | Director | Profile | |
| Anastasya Molodykh | Director | Profile | |
| Bruce Brown | Independent Director | Profile | |
| Matthew Norton | Independent Director | Profile |
How to buy Medpace Stock?
Before investing in Medpace Holdings, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Medpace Holdings. To buy Medpace Holdings stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Medpace Holdings. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Medpace Holdings stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Medpace Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Medpace Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Medpace Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Medpace Stock please use our How to Invest in Medpace Holdings guide.
Already Invested in Medpace Holdings?
The danger of trading Medpace Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Medpace Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Medpace Holdings. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Medpace Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Medpace Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medpace Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medpace Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Medpace Holdings Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.165 | Earnings Share 8.89 | Revenue Per Share 61.384 | Quarterly Revenue Growth 0.265 | Return On Assets 0.1399 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.